EUVIMEDEUVIMED entdecken
Korrektur

Correction to “Metformin vs Myoinositol: Which Is Better in Obese Polycystic Ovary Syndrome Patients? A Randomized Controlled Crossover Study”

Clinical Endocrinology · 2026-12 · 105 (6) · 680-681

DOI: 10.1111/cen.70207 ↗

Kurz gefasst

Korrektur in der Zeitschrift Clinical Endocrinology, online erschienen am 15.09.2026.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Zitieren

APA

(2026). Correction to “Metformin vs Myoinositol: Which Is Better in Obese Polycystic Ovary Syndrome Patients? A Randomized Controlled Crossover Study”. Clinical Endocrinology, 105(6), 680-681. https://doi.org/10.1111/cen.70207

Vancouver

Correction to “Metformin vs Myoinositol: Which Is Better in Obese Polycystic Ovary Syndrome Patients? A Randomized Controlled Crossover Study”. Clinical Endocrinology. 2026;105(6):680-681. doi:10.1111/cen.70207

BibTeX
@article{euvimed2026,
  title = {Correction to “Metformin vs Myoinositol: Which Is Better in Obese Polycystic Ovary Syndrome Patients? A Randomized Controlled Crossover Study”},
  journal = {Clinical Endocrinology},
  year = {2026},
  volume = {105},
  number = {6},
  pages = {680--681},
  doi = {10.1111/cen.70207}
}
Kostenlos starten →